SlideShare a Scribd company logo
NCHS Data Brief  ■  No. 59  ■  March 2011
u.s. department of health and human services
Centers for Disease Control and Prevention
National Center for Health Statistics
Vitamin D Status: United States, 2001–2006
Anne C. Looker, Ph.D.; Clifford L. Johnson, M.P.H.; David A. Lacher, M.D.; Christine M. Pfeiffer, Ph.D.;
Rosemary L. Schleicher, Ph.D.; and Christopher T. Sempos, Ph.D.
The Institute of Medicine (IOM) recently released new dietary reference
intakes for calcium and vitamin D (1). The IOM defined four categories of
vitamin D status based on serum 25-hydroxyvitamin D (25OHD): (i) risk
of deficiency, (ii) risk of inadequacy, (iii) sufficiency, and (iv) above which
there may be reason for concern (1). This brief presents the most recent
national data on vitamin D status in the U.S. population based on these IOM
categories. Results are presented by age, sex, race and ethnicity, and, for
women, by pregnancy and lactation status.
Keywords: serum 25-hydroxyvitamin D • prevalence • deficiency • inadequacy
In 2001–2006, what was the vitamin D status of the U.S.
population based on the IOM thresholds for serum 25OHD?
In 2001–2006, two-thirds (67%) of persons aged 1 year and over had serum
25OHD values considered sufficient (Figure 1). Roughly one quarter of the
population had serum 25OHD values that put them at risk of inadequacy.
Eight percent were at risk of deficiency, and 1% had a high serum 25OHD
value that may possibly be harmful. Serum 25OHD percentile values, which
provide a more detailed description of the serum 25OHD distribution in the
U.S. population, are shown in the Table.
Key findings
Data from the National
Health and Nutrition
Examination Surveys
(NHANES)
In 2001–2006, two-thirds of•	
the population had sufficient
vitamin D, defined by the
Institute of Medicine as a
serum 25-hydroxyvitamin D
(25OHD) value of 50–125
nmol/L. About one-quarter
were at risk of vitamin D
inadequacy (serum 25OHD
30–49 nmol/L), and 8% were
at risk of vitamin D deficiency
(serum 25OHD less than 30
nmol/L).
The risk of vitamin D•	
deficiency differed by age,
sex, and race and ethnicity.
The prevalence was lower in
persons who were younger,
male, or non-Hispanic
white. Among women, the
prevalence at risk was also
lower in pregnant or lactating
women.
The risk of vitamin D•	
deficiency increased between
1988–1994 and 2001–2002 in
both sexes but did not change
between 2001–2002 and
2005–2006.
NCHS Data Brief ■ No. 59 ■ March 2011
■  2  ■
Table. Selected percentile values for serum 25-hydroxyvitamin D (25OHD), by sex and age, and by pregnancy
and lactation status in females: United States, 2001–2006
Serum 25OHD (nmol/L) percentile
Characteristic n 5th 10th 25th 50th 75th 90th 95th
Male
Age (years)
1–3 581 40.7 48.3 58.2 69.5 84.4 94.7 101.0
4–8 970 42.6 47.8 58.0 67.3 78.8 92.0 99.9
9–13 1,473 32.5 40.4 49.9 62.1 74.5 87.4 98.5
14–18 1,978 25.3 33.0 45.7 58.5 71.2 84.9 95.7
19–30 1,611 23.0 29.4 41.9 55.3 68.7 83.6 94.3
31–50 2,244 25.1 31.3 44.2 57.4 71.5 84.5 94.3
51–70 1,853 25.6 32.7 44.1 58.1 71.3 83.7 91.8
Over 70 1,217 25.4 31.7 44.6 57.2 69.7 82.7 90.1
Female
Age (years)
1–3 584 43.3 49.8 58.5 68.3 79.4 89.2 94.9
4–8 989 38.4 44.2 54.5 67.2 80.0 93.4 101.0
9–13 1,515 27.7 34.6 46.3 57.6 68.4 80.9 87.5
14–18 1,823 20.8 27.2 41.1 57.2 71.6 87.1 104.0
19–30 1,346 18.5 25.4 40.0 55.9 76.2 95.6 111.0
31–50 2,097 19.2 25.3 38.9 55.3 71.0 87.6 101.0
51–70 1,866 21.2 27.0 39.7 54.7 69.7 85.4 93.4
Over 70 1,197 22.6 27.1 40.5 55.5 69.6 84.1 93.6
Pregnant or
lactating
1,067 24.5 31.4 44.5 62.4 78.2 94.7 109.0
SOURCE: CDC/NCHS, National Health and Nutrition Examination Survey (NHANES), 2001–2006; data for ages 1–5 years from NHANES 2003–2006.
What is the prevalence of serum 25OHD values indicating risk of deficiency,
by age and sex?
The season-adjusted prevalence at risk of deficiency by age ranged from 1% to 8% in males and
1% to 12% in females (Figure 2). In both sexes, the prevalence was lowest in children aged 1–8
years. Risk of deficiency increased significantly with age until age 30 in males and age 18 in
females, after which it did not change significantly with age.
NCHS Data Brief ■ No. 59 ■ March 2011
■  3  ■
What is the prevalence of serum 25OHD values indicating risk of
inadequacy, by age and sex?
The season-adjusted prevalence at risk of inadequacy by age ranged from 9% to 28% in males
and 11% to 28% in females (Figure 3). In both sexes, the prevalence was lowest in children aged
1–8 years. Risk of inadequacy increased significantly with age until age 30 in males, after which
it did not change further with age. Risk of inadequacy increased significantly with age until age
14 years in females. After age 14, risk of inadequacy among females remained constant until
age 51, when it increased significantly. After the increase at age 51, risk of inadequacy remained
stable in females.
NCHS Data Brief  ■  No. 59  ■  March 2011
■  4  ■
Does the prevalence of serum 25OHD values indicating risk of deficiency
and inadequacy differ by sex or race and ethnicity? Among women of
childbearing age, does this prevalence differ by pregnancy and lactation
status?
Males were less likely to be at risk of deficiency than females, after adjusting for age and
season (Figure 4). The age- and season-adjusted prevalence at risk of inadequacy did not differ
by sex. Non-Hispanic white persons were less likely to be at risk of deficiency or at risk of
inadequacy than non-Hispanic black or Mexican American persons, after adjusting for age and
season. According to IOM (1), interpretation of serum 25OHD thresholds for risk of deficiency
or inadequacy in nonwhite persons is uncertain because many nonwhite groups have better
skeletal status than white persons despite having lower serum 25OHD values. Among women of
childbearing age, those who were pregnant or lactating were less likely to be at risk of deficiency
than women who were not pregnant or lactating, after adjusting for age and season. The age- and
season-adjusted prevalence at risk of inadequacy did not differ by pregnancy and lactation status
in women of childbearing age.
NCHS Data Brief ■ No. 59 ■ March 2011
■  5  ■
Has the prevalence at risk of deficiency and inadequacy changed since
the 1990s?
In 1988–1994, 4% of males aged 12 years and over had serum 25OHD values that put them at
risk of deficiency, after adjusting for age and season; in comparison, the age- and season-adjusted
prevalence at risk of deficiency in 2001–2002 increased to 7% (Figure 5). The corresponding
figures for those at risk of inadequacy were 17% and 22%, respectively. The age- and season-
adjusted prevalence at risk of deficiency or inadequacy did not change between 2001–2002 and
2005–2006 in adolescent and adult men.
The age- and season-adjusted prevalence at risk of deficiency also increased between 1988–1994
and 2001–2002 among females aged 12 years and over (Figure 5). In 1988–1994, 7% of females
aged 12 and over were at risk of deficiency, after adjusting for age and season, compared with
11% in 2001–2002. However, the age- and season-adjusted prevalence of adolescent and adult
women at risk of inadequacy decreased from 30% in 1988–1994 to 25% in 2001–2002. The
age- and season-adjusted prevalence at risk of deficiency or inadequacy did not change between
2001–2002 and 2005–2006 in adolescent and adult women.
NCHS Data Brief  ■  No. 59  ■  March 2011
■  6  ■
Summary
Most persons in the United States are sufficient in vitamin D, based on serum 25OHD thresholds
proposed by IOM. Roughly one-quarter were at risk of inadequacy and 8% were at risk of
deficiency. The prevalence at risk of deficiency or inadequacy differed by age, sex, and race
and ethnicity. Groups at lower risk included children, males, non-Hispanic white persons,
and pregnant or lactating women. Between 1988–1994 and 2001–2002, the prevalence at risk
of deficiency increased in adolescents and adults of both sexes, but the prevalence at risk of
deficiency or inadequacy did not change between 2001–2002 and 2005–2006.
Definitions
At risk of vitamin D deficiency: Serum 25OHD less than 30 nmol/L (12 ng/mL) (1).
At risk of vitamin D inadequacy: Serum 25OHD 30–49 nmol/L (12–19 ng/mL) (1).
Sufficient in vitamin D: Serum 25OHD 50–125 nmol/L (20–50 ng/mL) (1).
Possibly harmful vitamin D: Serum 25OHD greater than 125 nmol/L (50 ng/mL) (1).
Season: Two categories, based on month of blood draw: November–March and April–October.
Season is important to consider for two reasons: (i) vitamin D is produced in the skin by sunlight
exposure, so it varies by season; and (ii) for practical reasons, data are collected in NHANES in
the South during the winter and North during the summer.
NHANES III (1988–1994) serum 25OHD adjustment: The assay method used to measure serum
25OHD in NHANES III differed from the method used in NHANES 2001–2006. A statistical
adjustment was applied to the NHANES III serum 25OHD so that the data could be validly
compared with serum 25OHD from NHANES 2001–2006. Details about the adjustment have
been published elsewhere (2).
Data source and methods
NHANES data were used for these analyses. NHANES is a cross-sectional survey designed to
monitor the health and nutritional status of the civilian noninstitutionalized U.S. population (3).
The survey consists of interviews conducted in participants’ homes and standardized physical
examinations that include laboratory tests utilizing blood and urine specimens provided by
participants during the examination.
The NHANES sample is selected through a complex, multistage design that includes selection of
primary sampling units (counties), household segments within the counties, and finally sample
persons from selected households. The sample design includes oversampling to obtain reliable
estimates of health and nutritional measures for population subgroups. In 1988–1994 and 2001–
2006, non-Hispanic black and Mexican-American persons were oversampled. In 1999, NHANES
became a continuous survey, fielded on an ongoing basis. Each year of data collection is based on
a representative sample covering all ages of the civilian noninstitutionalized population. Public-
use data files are released in 2-year cycles.
NCHS Data Brief  ■  No. 59  ■  March 2011
■  7  ■
Sample weights, which account for the differential probabilities of selection, nonresponse,
and noncoverage, were incorporated into the estimation process. The standard errors of the
percentages were estimated using Taylor series linearization, a method that incorporates the
sample weights and sample design. Prevalence estimates were age adjusted to the 2000 U.S.
standard population using the following age groups: ages 1–8, 9–19, 20–39, 30–49, 50–69, and
70 and over (Figure 4; data by sex and race and ethnicity); ages 12–24, 25–34, and 35–44
(Figure 4; data by pregnancy or lactation status); and ages 12–29, 30–49, 50–69, and 70 and over
(Figure 5). Serum 25OHD data were statistically adjusted for season when making comparisons
by age, sex, race and ethnicity, and pregnancy or lactation status, to control for differences in
the time of year when blood was drawn in different groups. Differences between groups were
evaluated using a t statistic at the p < 0.05 significance level. Tests of trends were done using the
p < 0.05 significance level. All results presented have a relative standard error
All differences reported are statistically significant unless otherwise indicated. Statistical analyses
were conducted using the SAS System for Windows (release 9.2; SAS Institute, Cary, NC) and
SUDAAN (release 10.0; Research Triangle Institute, Research Triangle Park, NC).
About the authors
Anne C. Looker, Clifford L. Johnson, and David A. Lacher are with the Centers for Disease
Control and Prevention’s (CDC) National Center for Health Statistics, Division of Health and
Nutrition Examination Surveys. Christine M. Pfeiffer and Rosemary L. Schleicher are with
CDC’s National Center for Environmental Health, Division of Laboratory Sciences. Christopher
T. Sempos is with the National Institutes of Health, Office of Dietary Supplements.
References
Institute of Medicine. Dietary reference intakes for calcium and vitamin D. Washington, DC:1.	
National Academies Press. 2010.
Looker AC, Pfeiffer CM, Lacher DA, Schleicher RL, Picciano MF, Yetley EA. Serum 25-2.	
hydroxyvitamin D status of the U.S. population: 1988–1994 compared with 2000–2004. Am J
Clin Nutr 88(6):1519–27. 2008.
National Center for Health Statistics. National Health and Nutrition Examination Survey,3.	
2001–2006. Available from: http://www.cdc.gov/nchs/nhanes/nhanes_questionnaires.htm.
Accessed February 25, 2011.
NCHS Data Brief   ■  No. 59  ■  March 2011
Suggested citation
Looker AC, Johnson CL, Lacher DA, et al.
Vitamin D status: United States, 2001–2006.
NCHS data brief, no 59. Hyattsville, MD:
National Center for Health Statistics. 2011.
Copyright information
All material appearing in this report is in
the public domain and may be reproduced
or copied without permission; citation as to
source, however, is appreciated.
National Center for Health
Statistics
Edward J. Sondik, Ph.D., Director
Jennifer H. Madans, Ph.D., Associate
Director for Science
Division of Health and Nutrition
Examination Surveys
Clifford L. Johnson, M.S.P.H., Director
U.S. Department of
Health & Human Services
Centers for Disease Control and Prevention
National Center for Health Statistics
3311 Toledo Road
Hyattsville, MD 20782
Official Business 
Penalty for Private Use, $300
To receive this publication regularly, contact the
National Center for Health Statistics by
calling 1–800–232–4636
E-mail: cdcinfo@cdc.gov
Internet: http://www.cdc.gov/nchs
First Class mAIL
Postage & Fees Paid
CDC/NCHS
Permit No. G-284
ISSN 1941–4927 (Print ed.)
ISSN 1941–4935 (Online ed.)
CS221202
T38775 (03/2011)
DHHS Publication No. (PHS) 2011–1209

More Related Content

What's hot

Life expectancy
Life expectancyLife expectancy
Life expectancy
Gaetan Lion
 
Risking our future
Risking our futureRisking our future
Athanasios Andriopoulos_final (2)
Athanasios Andriopoulos_final (2)Athanasios Andriopoulos_final (2)
Athanasios Andriopoulos_final (2)Thanos Andriopoulos
 
Global Burden of Diseases - Methodologies
Global Burden of Diseases - MethodologiesGlobal Burden of Diseases - Methodologies
Global Burden of Diseases - Methodologies
vi research
 
Vitamin D Deficiency in Association with HSCRP Linked to Obesity
Vitamin D Deficiency in Association with HSCRP Linked to ObesityVitamin D Deficiency in Association with HSCRP Linked to Obesity
Vitamin D Deficiency in Association with HSCRP Linked to Obesity
ijtsrd
 
Human life expectancy
Human life expectancyHuman life expectancy
Human life expectancy
Other Mother
 
Alberta Diabetes Surveillance System (ADSS) - Diabetes Atlas: Diabetes in Fir...
Alberta Diabetes Surveillance System (ADSS) - Diabetes Atlas: Diabetes in Fir...Alberta Diabetes Surveillance System (ADSS) - Diabetes Atlas: Diabetes in Fir...
Alberta Diabetes Surveillance System (ADSS) - Diabetes Atlas: Diabetes in Fir...
Kelli Buckreus
 
Cancer incidence in Malawi: Time trends in Blantyre 1996-2005 and predictions...
Cancer incidence in Malawi: Time trends in Blantyre 1996-2005 and predictions...Cancer incidence in Malawi: Time trends in Blantyre 1996-2005 and predictions...
Cancer incidence in Malawi: Time trends in Blantyre 1996-2005 and predictions...Humphrey Misiri
 
Srivastava Rakesh cells Research paper
 Srivastava Rakesh  cells  Research paper Srivastava Rakesh  cells  Research paper
Srivastava Rakesh cells Research paper
RakeshSrivastava87
 
US Ethnicity and Cancer, Learning from the World (B Blauvelt Innovara)
US Ethnicity and Cancer, Learning from the World (B Blauvelt Innovara)US Ethnicity and Cancer, Learning from the World (B Blauvelt Innovara)
US Ethnicity and Cancer, Learning from the World (B Blauvelt Innovara)
Innovara, Inc.
 
The Global Burden of Disease (GBD) study
The Global Burden of Disease (GBD) studyThe Global Burden of Disease (GBD) study
The Global Burden of Disease (GBD) study
Δρ. Γιώργος K. Κασάπης
 
U.S. County Life Expectancy, 1989-2009, Ali Mokdad, April 2012
U.S. County Life Expectancy, 1989-2009, Ali Mokdad, April 2012U.S. County Life Expectancy, 1989-2009, Ali Mokdad, April 2012
U.S. County Life Expectancy, 1989-2009, Ali Mokdad, April 2012
Institute for Health Metrics and Evaluation - University of Washington
 
Jgh3 4-351
Jgh3 4-351Jgh3 4-351
Jgh3 4-351
rakeshsrivastava89
 
Determinants of mortality
Determinants of mortalityDeterminants of mortality
Determinants of mortality
Basanta Chalise
 
Higher expression of SATB2 in hepatocellular carcinoma of African Americans d...
Higher expression of SATB2 in hepatocellular carcinoma of African Americans d...Higher expression of SATB2 in hepatocellular carcinoma of African Americans d...
Higher expression of SATB2 in hepatocellular carcinoma of African Americans d...
rakeshsrivastava89
 
Life expectancy: a comparison
Life expectancy: a comparisonLife expectancy: a comparison
Life expectancy: a comparison
Dipnarayan Thakur
 

What's hot (20)

Life expectancy
Life expectancyLife expectancy
Life expectancy
 
Risking our future
Risking our futureRisking our future
Risking our future
 
Mortality
MortalityMortality
Mortality
 
Financing global health 2011 global health council 011912_ihme
Financing global health 2011 global health council 011912_ihmeFinancing global health 2011 global health council 011912_ihme
Financing global health 2011 global health council 011912_ihme
 
Athanasios Andriopoulos_final (2)
Athanasios Andriopoulos_final (2)Athanasios Andriopoulos_final (2)
Athanasios Andriopoulos_final (2)
 
Global Burden of Diseases - Methodologies
Global Burden of Diseases - MethodologiesGlobal Burden of Diseases - Methodologies
Global Burden of Diseases - Methodologies
 
Vitamin D Deficiency in Association with HSCRP Linked to Obesity
Vitamin D Deficiency in Association with HSCRP Linked to ObesityVitamin D Deficiency in Association with HSCRP Linked to Obesity
Vitamin D Deficiency in Association with HSCRP Linked to Obesity
 
Human life expectancy
Human life expectancyHuman life expectancy
Human life expectancy
 
Alberta Diabetes Surveillance System (ADSS) - Diabetes Atlas: Diabetes in Fir...
Alberta Diabetes Surveillance System (ADSS) - Diabetes Atlas: Diabetes in Fir...Alberta Diabetes Surveillance System (ADSS) - Diabetes Atlas: Diabetes in Fir...
Alberta Diabetes Surveillance System (ADSS) - Diabetes Atlas: Diabetes in Fir...
 
GBD 2010 press conference
GBD 2010 press conferenceGBD 2010 press conference
GBD 2010 press conference
 
Cancer incidence in Malawi: Time trends in Blantyre 1996-2005 and predictions...
Cancer incidence in Malawi: Time trends in Blantyre 1996-2005 and predictions...Cancer incidence in Malawi: Time trends in Blantyre 1996-2005 and predictions...
Cancer incidence in Malawi: Time trends in Blantyre 1996-2005 and predictions...
 
Srivastava Rakesh cells Research paper
 Srivastava Rakesh  cells  Research paper Srivastava Rakesh  cells  Research paper
Srivastava Rakesh cells Research paper
 
US Ethnicity and Cancer, Learning from the World (B Blauvelt Innovara)
US Ethnicity and Cancer, Learning from the World (B Blauvelt Innovara)US Ethnicity and Cancer, Learning from the World (B Blauvelt Innovara)
US Ethnicity and Cancer, Learning from the World (B Blauvelt Innovara)
 
The Global Burden of Disease (GBD) study
The Global Burden of Disease (GBD) studyThe Global Burden of Disease (GBD) study
The Global Burden of Disease (GBD) study
 
U.S. County Life Expectancy, 1989-2009, Ali Mokdad, April 2012
U.S. County Life Expectancy, 1989-2009, Ali Mokdad, April 2012U.S. County Life Expectancy, 1989-2009, Ali Mokdad, April 2012
U.S. County Life Expectancy, 1989-2009, Ali Mokdad, April 2012
 
Jgh3 4-351
Jgh3 4-351Jgh3 4-351
Jgh3 4-351
 
omolafearticle
omolafearticleomolafearticle
omolafearticle
 
Determinants of mortality
Determinants of mortalityDeterminants of mortality
Determinants of mortality
 
Higher expression of SATB2 in hepatocellular carcinoma of African Americans d...
Higher expression of SATB2 in hepatocellular carcinoma of African Americans d...Higher expression of SATB2 in hepatocellular carcinoma of African Americans d...
Higher expression of SATB2 in hepatocellular carcinoma of African Americans d...
 
Life expectancy: a comparison
Life expectancy: a comparisonLife expectancy: a comparison
Life expectancy: a comparison
 

Similar to Cdc vit d

CDC 2012 Diet & Nutrition Report Summary
CDC 2012 Diet & Nutrition Report SummaryCDC 2012 Diet & Nutrition Report Summary
CDC 2012 Diet & Nutrition Report Summary
JA Larson
 
Prevalence of anemia in adolescent girls and its co relation with demographic...
Prevalence of anemia in adolescent girls and its co relation with demographic...Prevalence of anemia in adolescent girls and its co relation with demographic...
Prevalence of anemia in adolescent girls and its co relation with demographic...Younis I Munshi
 
Life exp. fas canada
Life exp. fas canadaLife exp. fas canada
Life exp. fas canada
BARRY STANLEY 2 fasd
 
Focusing on 12 gm Haemoglobin for Children, Girls & Women in INDIA : Dr Shard...
Focusing on 12 gm Haemoglobin for Children, Girls & Women in INDIA : Dr Shard...Focusing on 12 gm Haemoglobin for Children, Girls & Women in INDIA : Dr Shard...
Focusing on 12 gm Haemoglobin for Children, Girls & Women in INDIA : Dr Shard...
Lifecare Centre
 
Epidemiology of coronary artery disease
Epidemiology of coronary artery diseaseEpidemiology of coronary artery disease
Epidemiology of coronary artery disease
Harivansh Chopra
 
Epidemiology diabetes
Epidemiology diabetesEpidemiology diabetes
Epidemiology diabetes
Riyaz Khan
 
Prevalence of anemia and socio-demographic factors associated with anemia amo...
Prevalence of anemia and socio-demographic factors associated with anemia amo...Prevalence of anemia and socio-demographic factors associated with anemia amo...
Prevalence of anemia and socio-demographic factors associated with anemia amo...
IOSR Journals
 
Birth complications re vit d levels
Birth complications re vit d levelsBirth complications re vit d levels
Birth complications re vit d levels
JA Larson
 
IP TV Service
IP TV ServiceIP TV Service
IP TV Service
abushihab7
 
Risk factors in Multiple Sclerosis: Detection and Treatment in Daily Life
Risk factors in Multiple Sclerosis: Detection and Treatment in Daily LifeRisk factors in Multiple Sclerosis: Detection and Treatment in Daily Life
Risk factors in Multiple Sclerosis: Detection and Treatment in Daily Life
Swiss Multiple Sclerosis Society
 
The Effect Race and Income on HIV AIDS infection in African-Americans - Sunil...
The Effect Race and Income on HIV AIDS infection in African-Americans - Sunil...The Effect Race and Income on HIV AIDS infection in African-Americans - Sunil...
The Effect Race and Income on HIV AIDS infection in African-Americans - Sunil...
Sunil Nair
 
A Community Assessment of Nutritional Needs/Status of HIV/AIDS among Latinos ...
A Community Assessment of Nutritional Needs/Status of HIV/AIDS among Latinos ...A Community Assessment of Nutritional Needs/Status of HIV/AIDS among Latinos ...
A Community Assessment of Nutritional Needs/Status of HIV/AIDS among Latinos ...Kayoko Takada (Zahn)
 
Chapter 4Descriptive Epidemiology Person, Place, TimeLe
Chapter 4Descriptive Epidemiology Person, Place, TimeLeChapter 4Descriptive Epidemiology Person, Place, TimeLe
Chapter 4Descriptive Epidemiology Person, Place, TimeLe
WilheminaRossi174
 
Module 1: Determinants of Health
Module 1: Determinants of HealthModule 1: Determinants of Health
Module 1: Determinants of Health
AlyssaLitvaitis
 
Alcohol-related deaths have increased in recent years in U.S.
Alcohol-related deaths have increased in recent years in U.S.Alcohol-related deaths have increased in recent years in U.S.
Alcohol-related deaths have increased in recent years in U.S.
Δρ. Γιώργος K. Κασάπης
 
Ferrodyn 03 iron gyo
Ferrodyn 03 iron gyoFerrodyn 03 iron gyo
Ferrodyn 03 iron gyo
Roberto Conte
 
Mortality and Morbidity what are the major health problems in.docx
Mortality and Morbidity what are the major health problems in.docxMortality and Morbidity what are the major health problems in.docx
Mortality and Morbidity what are the major health problems in.docx
gilpinleeanna
 
Vita D Defic Insuffic Pregnancy Johnson Am J Perinatol 2010
Vita D Defic Insuffic Pregnancy Johnson Am J Perinatol 2010Vita D Defic Insuffic Pregnancy Johnson Am J Perinatol 2010
Vita D Defic Insuffic Pregnancy Johnson Am J Perinatol 2010alisonegypt
 
Vita d defic insuffic pregnancy johnson am j perinatol 2010
Vita d defic insuffic pregnancy johnson am j perinatol 2010Vita d defic insuffic pregnancy johnson am j perinatol 2010
Vita d defic insuffic pregnancy johnson am j perinatol 2010Alison Stevens
 
Module 1 determinants_of_health
Module 1 determinants_of_healthModule 1 determinants_of_health
Module 1 determinants_of_health
rafat naim
 

Similar to Cdc vit d (20)

CDC 2012 Diet & Nutrition Report Summary
CDC 2012 Diet & Nutrition Report SummaryCDC 2012 Diet & Nutrition Report Summary
CDC 2012 Diet & Nutrition Report Summary
 
Prevalence of anemia in adolescent girls and its co relation with demographic...
Prevalence of anemia in adolescent girls and its co relation with demographic...Prevalence of anemia in adolescent girls and its co relation with demographic...
Prevalence of anemia in adolescent girls and its co relation with demographic...
 
Life exp. fas canada
Life exp. fas canadaLife exp. fas canada
Life exp. fas canada
 
Focusing on 12 gm Haemoglobin for Children, Girls & Women in INDIA : Dr Shard...
Focusing on 12 gm Haemoglobin for Children, Girls & Women in INDIA : Dr Shard...Focusing on 12 gm Haemoglobin for Children, Girls & Women in INDIA : Dr Shard...
Focusing on 12 gm Haemoglobin for Children, Girls & Women in INDIA : Dr Shard...
 
Epidemiology of coronary artery disease
Epidemiology of coronary artery diseaseEpidemiology of coronary artery disease
Epidemiology of coronary artery disease
 
Epidemiology diabetes
Epidemiology diabetesEpidemiology diabetes
Epidemiology diabetes
 
Prevalence of anemia and socio-demographic factors associated with anemia amo...
Prevalence of anemia and socio-demographic factors associated with anemia amo...Prevalence of anemia and socio-demographic factors associated with anemia amo...
Prevalence of anemia and socio-demographic factors associated with anemia amo...
 
Birth complications re vit d levels
Birth complications re vit d levelsBirth complications re vit d levels
Birth complications re vit d levels
 
IP TV Service
IP TV ServiceIP TV Service
IP TV Service
 
Risk factors in Multiple Sclerosis: Detection and Treatment in Daily Life
Risk factors in Multiple Sclerosis: Detection and Treatment in Daily LifeRisk factors in Multiple Sclerosis: Detection and Treatment in Daily Life
Risk factors in Multiple Sclerosis: Detection and Treatment in Daily Life
 
The Effect Race and Income on HIV AIDS infection in African-Americans - Sunil...
The Effect Race and Income on HIV AIDS infection in African-Americans - Sunil...The Effect Race and Income on HIV AIDS infection in African-Americans - Sunil...
The Effect Race and Income on HIV AIDS infection in African-Americans - Sunil...
 
A Community Assessment of Nutritional Needs/Status of HIV/AIDS among Latinos ...
A Community Assessment of Nutritional Needs/Status of HIV/AIDS among Latinos ...A Community Assessment of Nutritional Needs/Status of HIV/AIDS among Latinos ...
A Community Assessment of Nutritional Needs/Status of HIV/AIDS among Latinos ...
 
Chapter 4Descriptive Epidemiology Person, Place, TimeLe
Chapter 4Descriptive Epidemiology Person, Place, TimeLeChapter 4Descriptive Epidemiology Person, Place, TimeLe
Chapter 4Descriptive Epidemiology Person, Place, TimeLe
 
Module 1: Determinants of Health
Module 1: Determinants of HealthModule 1: Determinants of Health
Module 1: Determinants of Health
 
Alcohol-related deaths have increased in recent years in U.S.
Alcohol-related deaths have increased in recent years in U.S.Alcohol-related deaths have increased in recent years in U.S.
Alcohol-related deaths have increased in recent years in U.S.
 
Ferrodyn 03 iron gyo
Ferrodyn 03 iron gyoFerrodyn 03 iron gyo
Ferrodyn 03 iron gyo
 
Mortality and Morbidity what are the major health problems in.docx
Mortality and Morbidity what are the major health problems in.docxMortality and Morbidity what are the major health problems in.docx
Mortality and Morbidity what are the major health problems in.docx
 
Vita D Defic Insuffic Pregnancy Johnson Am J Perinatol 2010
Vita D Defic Insuffic Pregnancy Johnson Am J Perinatol 2010Vita D Defic Insuffic Pregnancy Johnson Am J Perinatol 2010
Vita D Defic Insuffic Pregnancy Johnson Am J Perinatol 2010
 
Vita d defic insuffic pregnancy johnson am j perinatol 2010
Vita d defic insuffic pregnancy johnson am j perinatol 2010Vita d defic insuffic pregnancy johnson am j perinatol 2010
Vita d defic insuffic pregnancy johnson am j perinatol 2010
 
Module 1 determinants_of_health
Module 1 determinants_of_healthModule 1 determinants_of_health
Module 1 determinants_of_health
 

More from JA Larson

Why therapists are worried about america’s growing mental health crisis the...
Why therapists are worried about america’s growing mental health crisis   the...Why therapists are worried about america’s growing mental health crisis   the...
Why therapists are worried about america’s growing mental health crisis the...
JA Larson
 
Mazon military-hunger-report-april-2021
Mazon military-hunger-report-april-2021Mazon military-hunger-report-april-2021
Mazon military-hunger-report-april-2021
JA Larson
 
Army National guard health
Army National guard healthArmy National guard health
Army National guard health
JA Larson
 
Army reserve health
Army reserve healthArmy reserve health
Army reserve health
JA Larson
 
Army Active duty soldier health
Army Active duty soldier healthArmy Active duty soldier health
Army Active duty soldier health
JA Larson
 
2020 Army Health of the Force EXSUM
2020 Army Health of the Force EXSUM2020 Army Health of the Force EXSUM
2020 Army Health of the Force EXSUM
JA Larson
 
DOD 2020 Health of the Force
DOD 2020 Health of the ForceDOD 2020 Health of the Force
DOD 2020 Health of the Force
JA Larson
 
2020 Army Health of the Force
2020 Army Health of the Force2020 Army Health of the Force
2020 Army Health of the Force
JA Larson
 
Small Arms Lethality variables 1.6e DRAFT
Small Arms Lethality variables 1.6e DRAFTSmall Arms Lethality variables 1.6e DRAFT
Small Arms Lethality variables 1.6e DRAFT
JA Larson
 
2021 Vitamin D in Ireland
2021 Vitamin D in Ireland2021 Vitamin D in Ireland
2021 Vitamin D in Ireland
JA Larson
 
Injury prevention system v2b3 draft
Injury prevention system v2b3 draftInjury prevention system v2b3 draft
Injury prevention system v2b3 draft
JA Larson
 
Conex 18
Conex 18Conex 18
Conex 18
JA Larson
 
Vit d covid 19 jan
Vit d covid 19 janVit d covid 19 jan
Vit d covid 19 jan
JA Larson
 
Scotland Vit D
Scotland Vit DScotland Vit D
Scotland Vit D
JA Larson
 
Barlows Pond 2019
Barlows Pond 2019Barlows Pond 2019
Barlows Pond 2019
JA Larson
 
D covid v3a
D covid v3aD covid v3a
D covid v3a
JA Larson
 
D covid alipio tan
D covid alipio tanD covid alipio tan
D covid alipio tan
JA Larson
 
D dosing intervals
D dosing intervalsD dosing intervals
D dosing intervals
JA Larson
 
D, magnesium and b12
D, magnesium and b12D, magnesium and b12
D, magnesium and b12
JA Larson
 
Vieth bones vit d
Vieth bones vit dVieth bones vit d
Vieth bones vit d
JA Larson
 

More from JA Larson (20)

Why therapists are worried about america’s growing mental health crisis the...
Why therapists are worried about america’s growing mental health crisis   the...Why therapists are worried about america’s growing mental health crisis   the...
Why therapists are worried about america’s growing mental health crisis the...
 
Mazon military-hunger-report-april-2021
Mazon military-hunger-report-april-2021Mazon military-hunger-report-april-2021
Mazon military-hunger-report-april-2021
 
Army National guard health
Army National guard healthArmy National guard health
Army National guard health
 
Army reserve health
Army reserve healthArmy reserve health
Army reserve health
 
Army Active duty soldier health
Army Active duty soldier healthArmy Active duty soldier health
Army Active duty soldier health
 
2020 Army Health of the Force EXSUM
2020 Army Health of the Force EXSUM2020 Army Health of the Force EXSUM
2020 Army Health of the Force EXSUM
 
DOD 2020 Health of the Force
DOD 2020 Health of the ForceDOD 2020 Health of the Force
DOD 2020 Health of the Force
 
2020 Army Health of the Force
2020 Army Health of the Force2020 Army Health of the Force
2020 Army Health of the Force
 
Small Arms Lethality variables 1.6e DRAFT
Small Arms Lethality variables 1.6e DRAFTSmall Arms Lethality variables 1.6e DRAFT
Small Arms Lethality variables 1.6e DRAFT
 
2021 Vitamin D in Ireland
2021 Vitamin D in Ireland2021 Vitamin D in Ireland
2021 Vitamin D in Ireland
 
Injury prevention system v2b3 draft
Injury prevention system v2b3 draftInjury prevention system v2b3 draft
Injury prevention system v2b3 draft
 
Conex 18
Conex 18Conex 18
Conex 18
 
Vit d covid 19 jan
Vit d covid 19 janVit d covid 19 jan
Vit d covid 19 jan
 
Scotland Vit D
Scotland Vit DScotland Vit D
Scotland Vit D
 
Barlows Pond 2019
Barlows Pond 2019Barlows Pond 2019
Barlows Pond 2019
 
D covid v3a
D covid v3aD covid v3a
D covid v3a
 
D covid alipio tan
D covid alipio tanD covid alipio tan
D covid alipio tan
 
D dosing intervals
D dosing intervalsD dosing intervals
D dosing intervals
 
D, magnesium and b12
D, magnesium and b12D, magnesium and b12
D, magnesium and b12
 
Vieth bones vit d
Vieth bones vit dVieth bones vit d
Vieth bones vit d
 

Recently uploaded

Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley LifesciencesPharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Yodley Lifesciences
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
ShashankRoodkee
 
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
chandankumarsmartiso
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 

Recently uploaded (20)

Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley LifesciencesPharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
 
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 

Cdc vit d

  • 1. NCHS Data Brief  ■  No. 59  ■  March 2011 u.s. department of health and human services Centers for Disease Control and Prevention National Center for Health Statistics Vitamin D Status: United States, 2001–2006 Anne C. Looker, Ph.D.; Clifford L. Johnson, M.P.H.; David A. Lacher, M.D.; Christine M. Pfeiffer, Ph.D.; Rosemary L. Schleicher, Ph.D.; and Christopher T. Sempos, Ph.D. The Institute of Medicine (IOM) recently released new dietary reference intakes for calcium and vitamin D (1). The IOM defined four categories of vitamin D status based on serum 25-hydroxyvitamin D (25OHD): (i) risk of deficiency, (ii) risk of inadequacy, (iii) sufficiency, and (iv) above which there may be reason for concern (1). This brief presents the most recent national data on vitamin D status in the U.S. population based on these IOM categories. Results are presented by age, sex, race and ethnicity, and, for women, by pregnancy and lactation status. Keywords: serum 25-hydroxyvitamin D • prevalence • deficiency • inadequacy In 2001–2006, what was the vitamin D status of the U.S. population based on the IOM thresholds for serum 25OHD? In 2001–2006, two-thirds (67%) of persons aged 1 year and over had serum 25OHD values considered sufficient (Figure 1). Roughly one quarter of the population had serum 25OHD values that put them at risk of inadequacy. Eight percent were at risk of deficiency, and 1% had a high serum 25OHD value that may possibly be harmful. Serum 25OHD percentile values, which provide a more detailed description of the serum 25OHD distribution in the U.S. population, are shown in the Table. Key findings Data from the National Health and Nutrition Examination Surveys (NHANES) In 2001–2006, two-thirds of• the population had sufficient vitamin D, defined by the Institute of Medicine as a serum 25-hydroxyvitamin D (25OHD) value of 50–125 nmol/L. About one-quarter were at risk of vitamin D inadequacy (serum 25OHD 30–49 nmol/L), and 8% were at risk of vitamin D deficiency (serum 25OHD less than 30 nmol/L). The risk of vitamin D• deficiency differed by age, sex, and race and ethnicity. The prevalence was lower in persons who were younger, male, or non-Hispanic white. Among women, the prevalence at risk was also lower in pregnant or lactating women. The risk of vitamin D• deficiency increased between 1988–1994 and 2001–2002 in both sexes but did not change between 2001–2002 and 2005–2006.
  • 2. NCHS Data Brief ■ No. 59 ■ March 2011 ■  2  ■ Table. Selected percentile values for serum 25-hydroxyvitamin D (25OHD), by sex and age, and by pregnancy and lactation status in females: United States, 2001–2006 Serum 25OHD (nmol/L) percentile Characteristic n 5th 10th 25th 50th 75th 90th 95th Male Age (years) 1–3 581 40.7 48.3 58.2 69.5 84.4 94.7 101.0 4–8 970 42.6 47.8 58.0 67.3 78.8 92.0 99.9 9–13 1,473 32.5 40.4 49.9 62.1 74.5 87.4 98.5 14–18 1,978 25.3 33.0 45.7 58.5 71.2 84.9 95.7 19–30 1,611 23.0 29.4 41.9 55.3 68.7 83.6 94.3 31–50 2,244 25.1 31.3 44.2 57.4 71.5 84.5 94.3 51–70 1,853 25.6 32.7 44.1 58.1 71.3 83.7 91.8 Over 70 1,217 25.4 31.7 44.6 57.2 69.7 82.7 90.1 Female Age (years) 1–3 584 43.3 49.8 58.5 68.3 79.4 89.2 94.9 4–8 989 38.4 44.2 54.5 67.2 80.0 93.4 101.0 9–13 1,515 27.7 34.6 46.3 57.6 68.4 80.9 87.5 14–18 1,823 20.8 27.2 41.1 57.2 71.6 87.1 104.0 19–30 1,346 18.5 25.4 40.0 55.9 76.2 95.6 111.0 31–50 2,097 19.2 25.3 38.9 55.3 71.0 87.6 101.0 51–70 1,866 21.2 27.0 39.7 54.7 69.7 85.4 93.4 Over 70 1,197 22.6 27.1 40.5 55.5 69.6 84.1 93.6 Pregnant or lactating 1,067 24.5 31.4 44.5 62.4 78.2 94.7 109.0 SOURCE: CDC/NCHS, National Health and Nutrition Examination Survey (NHANES), 2001–2006; data for ages 1–5 years from NHANES 2003–2006. What is the prevalence of serum 25OHD values indicating risk of deficiency, by age and sex? The season-adjusted prevalence at risk of deficiency by age ranged from 1% to 8% in males and 1% to 12% in females (Figure 2). In both sexes, the prevalence was lowest in children aged 1–8 years. Risk of deficiency increased significantly with age until age 30 in males and age 18 in females, after which it did not change significantly with age.
  • 3. NCHS Data Brief ■ No. 59 ■ March 2011 ■  3  ■ What is the prevalence of serum 25OHD values indicating risk of inadequacy, by age and sex? The season-adjusted prevalence at risk of inadequacy by age ranged from 9% to 28% in males and 11% to 28% in females (Figure 3). In both sexes, the prevalence was lowest in children aged 1–8 years. Risk of inadequacy increased significantly with age until age 30 in males, after which it did not change further with age. Risk of inadequacy increased significantly with age until age 14 years in females. After age 14, risk of inadequacy among females remained constant until age 51, when it increased significantly. After the increase at age 51, risk of inadequacy remained stable in females.
  • 4. NCHS Data Brief  ■  No. 59  ■  March 2011 ■  4  ■ Does the prevalence of serum 25OHD values indicating risk of deficiency and inadequacy differ by sex or race and ethnicity? Among women of childbearing age, does this prevalence differ by pregnancy and lactation status? Males were less likely to be at risk of deficiency than females, after adjusting for age and season (Figure 4). The age- and season-adjusted prevalence at risk of inadequacy did not differ by sex. Non-Hispanic white persons were less likely to be at risk of deficiency or at risk of inadequacy than non-Hispanic black or Mexican American persons, after adjusting for age and season. According to IOM (1), interpretation of serum 25OHD thresholds for risk of deficiency or inadequacy in nonwhite persons is uncertain because many nonwhite groups have better skeletal status than white persons despite having lower serum 25OHD values. Among women of childbearing age, those who were pregnant or lactating were less likely to be at risk of deficiency than women who were not pregnant or lactating, after adjusting for age and season. The age- and season-adjusted prevalence at risk of inadequacy did not differ by pregnancy and lactation status in women of childbearing age.
  • 5. NCHS Data Brief ■ No. 59 ■ March 2011 ■  5  ■ Has the prevalence at risk of deficiency and inadequacy changed since the 1990s? In 1988–1994, 4% of males aged 12 years and over had serum 25OHD values that put them at risk of deficiency, after adjusting for age and season; in comparison, the age- and season-adjusted prevalence at risk of deficiency in 2001–2002 increased to 7% (Figure 5). The corresponding figures for those at risk of inadequacy were 17% and 22%, respectively. The age- and season- adjusted prevalence at risk of deficiency or inadequacy did not change between 2001–2002 and 2005–2006 in adolescent and adult men. The age- and season-adjusted prevalence at risk of deficiency also increased between 1988–1994 and 2001–2002 among females aged 12 years and over (Figure 5). In 1988–1994, 7% of females aged 12 and over were at risk of deficiency, after adjusting for age and season, compared with 11% in 2001–2002. However, the age- and season-adjusted prevalence of adolescent and adult women at risk of inadequacy decreased from 30% in 1988–1994 to 25% in 2001–2002. The age- and season-adjusted prevalence at risk of deficiency or inadequacy did not change between 2001–2002 and 2005–2006 in adolescent and adult women.
  • 6. NCHS Data Brief  ■  No. 59  ■  March 2011 ■  6  ■ Summary Most persons in the United States are sufficient in vitamin D, based on serum 25OHD thresholds proposed by IOM. Roughly one-quarter were at risk of inadequacy and 8% were at risk of deficiency. The prevalence at risk of deficiency or inadequacy differed by age, sex, and race and ethnicity. Groups at lower risk included children, males, non-Hispanic white persons, and pregnant or lactating women. Between 1988–1994 and 2001–2002, the prevalence at risk of deficiency increased in adolescents and adults of both sexes, but the prevalence at risk of deficiency or inadequacy did not change between 2001–2002 and 2005–2006. Definitions At risk of vitamin D deficiency: Serum 25OHD less than 30 nmol/L (12 ng/mL) (1). At risk of vitamin D inadequacy: Serum 25OHD 30–49 nmol/L (12–19 ng/mL) (1). Sufficient in vitamin D: Serum 25OHD 50–125 nmol/L (20–50 ng/mL) (1). Possibly harmful vitamin D: Serum 25OHD greater than 125 nmol/L (50 ng/mL) (1). Season: Two categories, based on month of blood draw: November–March and April–October. Season is important to consider for two reasons: (i) vitamin D is produced in the skin by sunlight exposure, so it varies by season; and (ii) for practical reasons, data are collected in NHANES in the South during the winter and North during the summer. NHANES III (1988–1994) serum 25OHD adjustment: The assay method used to measure serum 25OHD in NHANES III differed from the method used in NHANES 2001–2006. A statistical adjustment was applied to the NHANES III serum 25OHD so that the data could be validly compared with serum 25OHD from NHANES 2001–2006. Details about the adjustment have been published elsewhere (2). Data source and methods NHANES data were used for these analyses. NHANES is a cross-sectional survey designed to monitor the health and nutritional status of the civilian noninstitutionalized U.S. population (3). The survey consists of interviews conducted in participants’ homes and standardized physical examinations that include laboratory tests utilizing blood and urine specimens provided by participants during the examination. The NHANES sample is selected through a complex, multistage design that includes selection of primary sampling units (counties), household segments within the counties, and finally sample persons from selected households. The sample design includes oversampling to obtain reliable estimates of health and nutritional measures for population subgroups. In 1988–1994 and 2001– 2006, non-Hispanic black and Mexican-American persons were oversampled. In 1999, NHANES became a continuous survey, fielded on an ongoing basis. Each year of data collection is based on a representative sample covering all ages of the civilian noninstitutionalized population. Public- use data files are released in 2-year cycles.
  • 7. NCHS Data Brief  ■  No. 59  ■  March 2011 ■  7  ■ Sample weights, which account for the differential probabilities of selection, nonresponse, and noncoverage, were incorporated into the estimation process. The standard errors of the percentages were estimated using Taylor series linearization, a method that incorporates the sample weights and sample design. Prevalence estimates were age adjusted to the 2000 U.S. standard population using the following age groups: ages 1–8, 9–19, 20–39, 30–49, 50–69, and 70 and over (Figure 4; data by sex and race and ethnicity); ages 12–24, 25–34, and 35–44 (Figure 4; data by pregnancy or lactation status); and ages 12–29, 30–49, 50–69, and 70 and over (Figure 5). Serum 25OHD data were statistically adjusted for season when making comparisons by age, sex, race and ethnicity, and pregnancy or lactation status, to control for differences in the time of year when blood was drawn in different groups. Differences between groups were evaluated using a t statistic at the p < 0.05 significance level. Tests of trends were done using the p < 0.05 significance level. All results presented have a relative standard error All differences reported are statistically significant unless otherwise indicated. Statistical analyses were conducted using the SAS System for Windows (release 9.2; SAS Institute, Cary, NC) and SUDAAN (release 10.0; Research Triangle Institute, Research Triangle Park, NC). About the authors Anne C. Looker, Clifford L. Johnson, and David A. Lacher are with the Centers for Disease Control and Prevention’s (CDC) National Center for Health Statistics, Division of Health and Nutrition Examination Surveys. Christine M. Pfeiffer and Rosemary L. Schleicher are with CDC’s National Center for Environmental Health, Division of Laboratory Sciences. Christopher T. Sempos is with the National Institutes of Health, Office of Dietary Supplements. References Institute of Medicine. Dietary reference intakes for calcium and vitamin D. Washington, DC:1. National Academies Press. 2010. Looker AC, Pfeiffer CM, Lacher DA, Schleicher RL, Picciano MF, Yetley EA. Serum 25-2. hydroxyvitamin D status of the U.S. population: 1988–1994 compared with 2000–2004. Am J Clin Nutr 88(6):1519–27. 2008. National Center for Health Statistics. National Health and Nutrition Examination Survey,3. 2001–2006. Available from: http://www.cdc.gov/nchs/nhanes/nhanes_questionnaires.htm. Accessed February 25, 2011.
  • 8. NCHS Data Brief   ■  No. 59  ■  March 2011 Suggested citation Looker AC, Johnson CL, Lacher DA, et al. Vitamin D status: United States, 2001–2006. NCHS data brief, no 59. Hyattsville, MD: National Center for Health Statistics. 2011. Copyright information All material appearing in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated. National Center for Health Statistics Edward J. Sondik, Ph.D., Director Jennifer H. Madans, Ph.D., Associate Director for Science Division of Health and Nutrition Examination Surveys Clifford L. Johnson, M.S.P.H., Director U.S. Department of Health & Human Services Centers for Disease Control and Prevention National Center for Health Statistics 3311 Toledo Road Hyattsville, MD 20782 Official Business Penalty for Private Use, $300 To receive this publication regularly, contact the National Center for Health Statistics by calling 1–800–232–4636 E-mail: cdcinfo@cdc.gov Internet: http://www.cdc.gov/nchs First Class mAIL Postage & Fees Paid CDC/NCHS Permit No. G-284 ISSN 1941–4927 (Print ed.) ISSN 1941–4935 (Online ed.) CS221202 T38775 (03/2011) DHHS Publication No. (PHS) 2011–1209